Denton John Russel
See Remarks
Denton John Russel has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Sep 23, 2026.
On the most recent filing, Denton John Russel is listed as See Remarks at Caris Life Sciences, Inc. Inside the rolling window, Denton John Russel reported 1 open-market purchase totaling $101K in CAI and 1 open-market sale totaling $239K in CAI. The largest disclosed transaction in the window is a sale of 7,500 CAI shares on Sep 22, 2026, worth $239K.
Companies traded
Other insiders at CAI
Insider Buying
$101K
reported purchases (SEC code P)
Insider Selling
$239K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Denton John Russel made?
Denton John Russel has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Denton John Russel trade?
Denton John Russel has filed SEC Form 4 disclosures for 1 company, including CAI.
When was Denton John Russel's most recent SEC Form 4 filing?
Denton John Russel's most recent SEC Form 4 filing on Tracefour is dated Sep 23, 2026.
What is Denton John Russel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Denton John Russel is listed as See Remarks.
What is Denton John Russel's total buy and sell value in the current window?
Inside the rolling retention window, Denton John Russel bought $101K and sold $239K based on SEC Form 4 filings.
What was Denton John Russel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,500 CAI shares on 2026-09-22, worth $239K, per SEC Form 4 filings.